| F.
NO. 8 (19)/99/DP/NPPA-Div.II Government Of India Ministry Of Chemicals And Fertilizers National Pharmaceutical Pricing Authority New Delhi, Dated The 27/08/99 Order In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof; |
 |
    |
| Table | ||||||
| Sl. No. | Name of the Formulation | Pack Size |
Existing Retail Price (Rs.) |
Retail Price without Excise Duty |
Excise Duty (Rs.) | Revised Retail Price with Excise Duty (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) | (7) |
| "1. | Restecline Capsules Each cap contain Tetracycline HCl 250 mg |
10's Al_Bl | 14.70 | 14.14 | 0.00 | 14.14 |
2. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of
(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
(b) the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
4. The prices given in Column 7 of the above table will remain valid subject to the conditions that the company purchases the bulk drug exclusively from indigenous manufacturer(s) and the company submits the return every month to the Government/NPPA regarding procurement (quantity and price) of the bulk drug and sale (quantity and price) of the formulation(s).
PN/26/99/F
M/s Synbiotics
Limited
Varodara
(K. K. Jain)
Deputy Director
National Pharmaceutical Pricing Authority